Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia : long-term clinical and MRD results of the German CLL Study Group CLL 3 X trial
Peter Dreger,1 Hartmut Döhner,2 Matthias Ritgen,3 Sebastian Böttcher,3 Raymonde Busch,4 Sascha Dietrich,1 Donald Bunjes,2 Sandra Cohen,5 Jörg Schubert,6 Ute Hegenbart,1 Dietrich Beelen,7 Matthias Zeis,8 Michael Stadler,9 Justin Hasenkamp,10 Lutz Uharek,11 Christof Scheid,12 Andreas Humpe,3 Thorsten Zenz,2 Dirk Winkler,2 Michael Hallek,12 Michael Kneba,3 Norbert Schmitz,8 and Stephan Stilgenbauer,2 for the German CLL Study Group